Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Oct 7, 2020- Data show ID NOW performance of 95.0% sensitivity and 97.9% specificity within seven days of symptom onset- ID NOW is the most studied COVID-19 test available; interim post-authorization study evaluated 1,003 people- To date, Abbott has shipped more than 12 million ID NOW tests to all 50 states and provided more than 30 million rapid and lab-based COVID-19 tests in the U.S. since March-
Sep 30, 2020- Low back pain affects one in 10 Americans and often impacts the patient physically, emotionally and economically- The multicenter, randomized, controlled DISTINCT study represents an Abbott collaboration with both spine surgeons and pain specialists to amass post-market evidence for its BurstDR™ spinal cord stimulation therapy for patients who have limited surgical options
Sep 28, 2020- The FreeStyle Libre 3 system automatically delivers real-time, up-to-the-minute glucose readings, unsurpassed 14-day accuracy[1] and optional glucose alarms directly to smartphones[2] for people with diabetes- With the smallest and thinnest[3] wearable glucose sensor (about the size of two stacked U.S. pennies), FreeStyle Libre 3 users can view their glucose levels discreetly[4] and conveniently,[5] anytime[6]- Building on the proven FreeStyle Libre 2 sensor performance with a new sensor design at the same affordable price as previous versions,[7] the FreeStyle Libre 3 system is the latest innovation of Abbott's world-leading[8] continuous glucose monitoring technology- Sep 21, 2020- CE Mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology- MitraClip is a first-of-its-kind transcatheter mitral valve therapy, now on its fourth generation, improving further on MitraClip's history as a safe and effective treatment option
Sep 17, 2020- Abbott's Libre Sense Glucose Sport Biosensor, with CE Mark, is built upon the company's world-leading continuous glucose monitoring technology- Abbott is collaborating with sports performance technology company Supersapiens to advance this first-of-its-kind product- As part of an observational trial, two cycling teams leading into the world's largest annual sporting event, the Tour de France, trained with Abbott's Libre Sense biosensor to track the correlation between glucose levels and their athletic performance- Sep 3, 2020- The LIFE-BTK trial will evaluate the company's new drug-eluting resorbable scaffold (DRS), known as the Esprit BTK System, for the treatment of blocked arteries below-the-knee (BTK)- Esprit BTK was granted breakthrough device designation by the U.S. FDA- There are no stents or drug-coated balloons currently approved for use below the knee in the U.S.
- Sep 1, 2020- U.S. Centers for Medicare & Medicaid Services (CMS) reimbursement expands access of the FreeStyle Libre 2 system to Medicare patients[1] to better manage their diabetes- The FreeStyle Libre 2 technology is the only integrated continuous glucose monitoring (iCGM) system available that continuously measures glucose data every minute without the need for painful fingersticks[2]- Widely available in the U.S., the FreeStyle Libre 2 system is priced 70% lower than other available continuous glucose monitoring devices[3]
Aug 26, 2020- Abbott's BinaxNOW™ COVID-19 Ag Card is a rapid, reliable, highly portable, and affordable tool for detecting active coronavirus infections at massive scale- Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5% in clinical study- Abbott to offer a no-charge complementary phone app, which allows people to display their BinaxNOW test results when asked by organizations where people gather, such as workplaces and schools- Company will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October